Q3 FY2026 · ended Jun 30, 2026 · Revenue $84.75B, +5.1% YoY · Filed Aug 5, 2026
Cencora, Inc. (COR) files with the SEC under industry code 5122, Wholesale-Drugs, Proprietaries & Druggists' Sundries. In Q3 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $84.8 billion and net income of $763.5 million. Free cash flow was $2.4 billion. As of Jun 30, 2026 it held $2.8 billion in cash and investments and $11.7 billion in total debt.
Company profile
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
- Listed as
- COR (NYSE)
- Fiscal year ends
- September 30
- Incorporated in
- DE
- Headquarters
- Conshohocken, PA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1140859
- Former names
- AMERISOURCEBERGEN CORP (until Aug 15, 2023); AMERISOURCE BERGEN CORP (until Oct 9, 2001)
Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
- Mckesson Corp MCK
- Cardinal Health Inc CAH
- Herbalife Ltd. HLF
- Nu Skin Enterprises, Inc. NUS
- EnerSyn Global Inc. ESYN
- Cosmos Health Inc. COSM
- DataMeds AI, Inc. MEDS
- Cellyan Biotechnology Co., Ltd HKPD
All 11 Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Jun 30, 2026 |
Q2 FY2026 Mar 31, 2026 |
Q1 FY2026 Dec 31, 2025 |
Q4 FY2025 Sep 30, 2025 |
Q3 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $84.8B | $78.4B | $85.9B | $83.7B | $80.7B |
| Operating income | $1.1B | $1.1B | $760.4M | $18.5M | $867.7M |
| Net income | $763.5M | $1.6B | $559.6M | -$339.7M | $687.4M |
| Diluted EPS | $3.94 | $8.40 | $2.87 | -$1.74 | $3.52 |
| Operating cash flow | $2.7B | $1.3B | -$2.3B | $3.1B | $109.2M |
| Free cash flow | $2.4B | $1.2B | -$2.4B | $2.9B | -$74.0M |
| Total assets | $83.8B | $81.7B | $78.4B | $76.6B | $74.0B |
| Stockholders' equity | $3.1B | $3.4B | $1.9B | $1.5B | $2.0B |
| Cash and investments | $2.8B | $2.2B | $1.8B | $4.4B | $2.2B |
| Total debt | $11.7B | $12.4B | $7.9B | $9.3B | $8.2B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 21, 2026 | Oct 21, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 25, 2026 | Sep 24, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 14, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 12, 2026 | Aug 12, 2026 |
All 1000 Cencora, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.